Herpes simplex vaccine live recombinant - MedImmune Vaccines
Alternative Names: AD-472; R 7017; R 7020Latest Information Update: 04 Apr 2022
At a glance
- Originator MedImmune Vaccines; sanofi pasteur
- Developer MedImmune Vaccines
- Class Viral vaccines; Viruses
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Herpes simplex virus infections
Most Recent Events
- 29 Sep 2004 Discontinued - Preclinical for Herpes simplex virus infections in USA (unspecified route)
- 30 Aug 2004 Aventis has merged with Sanofi-Synthélabo to form Sanofi-Aventis
- 03 Dec 2001 This vaccine is still in active development